Industry Trends Oxygen therapy devices, sleep diagnostic devices and respiratory disposables, are expected to be the fastest-growing segments in the European anesthesia, respiratory and sleep management device market. As an alternative to the centralized delivery of concentrated oxygen, devices that allow patients to generate their own oxygen at home have played a significant role. This
Overall, the market for sleep therapy interfaces is set to grow at a faster rate than the positive airway pressure device market. Specifically driving growth in that market is the full-face and nasal pillow options, as they offer greater patient comfort and have grown quite drastically in recent years. On the other hand, within the
The full report suite on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices includes anesthesia delivery units (ADU), anesthesia monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea (sleep therapy) devices and sleep diagnostic devices.
In 2021, the Europe anesthesia, respiratory and sleep therapy devices market size is estimated to reach €1.8 billion, with the Sleep Diagnostic Device market expected to experience the fastest growth. In spite of COVID19, the EU market size is projected to increase over the forecast period to exceed $1.8 billion in 2027. Currently, over 35%
Obstructive sleep apnea is a respiratory disorder wherein an individuals airway is obstructed during sleep as muscles relax and the airway walls and tissue collapse. The resulting asphyxia arouses the individual from the deeper stages of sleep so that normal breathing can be restored. It is this disruption of regular sleep rhythms that causes the negative symptoms associated with sleep apnea. During these events (termed apneic events), breathing ceases long enough to allow several normal breaths to be missed. In order to be considered an apneic event, a ten second interval between breaths and neurological arousal and/or blood oxygen desaturation are required. In most cases, the sufferer is unaware of experiencing such an event at the time, often simply falling back asleep afterwards.
The overall market for obstructive sleep apnea (OSA) therapy devices in Europe is segmented into two main device groups: PAP machines including CPAP, BiPAP and APAP variations, and facial interfaces including nasal masks, full-face masks and nasal/pillow alternative interfaces masks.